Kurt Beam
Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Channels, L-Type | 58 | 2022 | 117 | 8.940 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 38 | 2023 | 72 | 6.470 |
Why?
| | Calcium | 58 | 2023 | 1180 | 4.140 |
Why?
| | Calcium Channels | 48 | 2012 | 155 | 4.040 |
Why?
| | Muscle Fibers, Skeletal | 27 | 2022 | 216 | 3.540 |
Why?
| | Muscle, Skeletal | 45 | 2023 | 1712 | 3.250 |
Why?
| | Calcium Signaling | 18 | 2021 | 249 | 2.990 |
Why?
| | Ion Channel Gating | 18 | 2015 | 89 | 2.870 |
Why?
| | Muscle Contraction | 35 | 2012 | 429 | 2.470 |
Why?
| | Muscles | 38 | 2008 | 327 | 2.060 |
Why?
| | Excitation Contraction Coupling | 8 | 2022 | 17 | 1.770 |
Why?
| | Calcium Channels, N-Type | 2 | 2025 | 10 | 1.630 |
Why?
| | Nerve Tissue Proteins | 5 | 2018 | 592 | 1.630 |
Why?
| | Muscle Proteins | 15 | 2017 | 229 | 1.560 |
Why?
| | Muscular Diseases | 11 | 2016 | 112 | 1.320 |
Why?
| | Malignant Hyperthermia | 6 | 2023 | 8 | 1.250 |
Why?
| | Cell Membrane | 11 | 2025 | 710 | 1.200 |
Why?
| | Membrane Proteins | 3 | 2025 | 1151 | 1.140 |
Why?
| | Membrane Potentials | 23 | 2013 | 279 | 1.110 |
Why?
| | Neurons | 8 | 2021 | 1586 | 1.100 |
Why?
| | Cells, Cultured | 39 | 2018 | 4136 | 0.990 |
Why?
| | Animals | 114 | 2025 | 36882 | 0.960 |
Why?
| | Mice | 77 | 2023 | 17705 | 0.960 |
Why?
| | Luminescent Proteins | 10 | 2012 | 181 | 0.950 |
Why?
| | Animals, Newborn | 20 | 2018 | 832 | 0.900 |
Why?
| | Endoplasmic Reticulum | 2 | 2025 | 269 | 0.780 |
Why?
| | Mutation | 13 | 2023 | 3975 | 0.770 |
Why?
| | Electrophysiology | 24 | 2012 | 216 | 0.740 |
Why?
| | Action Potentials | 16 | 2022 | 491 | 0.730 |
Why?
| | Sarcoplasmic Reticulum | 13 | 2017 | 42 | 0.720 |
Why?
| | Recombinant Fusion Proteins | 12 | 2016 | 660 | 0.680 |
Why?
| | Mutation, Missense | 3 | 2013 | 338 | 0.670 |
Why?
| | Caveolin 1 | 3 | 2017 | 21 | 0.670 |
Why?
| | Motor Neurons | 9 | 1999 | 232 | 0.660 |
Why?
| | Rabbits | 19 | 2018 | 759 | 0.600 |
Why?
| | Cell Line | 10 | 2021 | 2855 | 0.550 |
Why?
| | Ion Channels | 9 | 1988 | 128 | 0.530 |
Why?
| | Myocardium | 11 | 2012 | 895 | 0.530 |
Why?
| | Mice, Mutant Strains | 17 | 2012 | 303 | 0.500 |
Why?
| | HEK293 Cells | 3 | 2025 | 727 | 0.490 |
Why?
| | Mutant Proteins | 1 | 2016 | 103 | 0.480 |
Why?
| | Amino Acid Sequence | 16 | 2015 | 2139 | 0.480 |
Why?
| | DNA, Complementary | 15 | 2012 | 275 | 0.470 |
Why?
| | Protein Binding | 9 | 2025 | 2223 | 0.460 |
Why?
| | Calcium Channel Blockers | 11 | 2009 | 166 | 0.450 |
Why?
| | Myoblasts, Skeletal | 2 | 2010 | 12 | 0.410 |
Why?
| | Molecular Sequence Data | 15 | 2015 | 2900 | 0.410 |
Why?
| | Kinetics | 15 | 2016 | 1635 | 0.410 |
Why?
| | Heart | 5 | 2001 | 609 | 0.410 |
Why?
| | Neuromuscular Junction | 5 | 2009 | 56 | 0.400 |
Why?
| | Dihydropyridines | 9 | 2003 | 15 | 0.400 |
Why?
| | Ryanodine | 3 | 2009 | 15 | 0.380 |
Why?
| | Protein Subunits | 6 | 2016 | 241 | 0.380 |
Why?
| | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 7 | 2013 | 11 | 0.380 |
Why?
| | Receptors, Nicotinic | 10 | 1991 | 344 | 0.360 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2022 | 428 | 0.340 |
Why?
| | Patch-Clamp Techniques | 9 | 2010 | 285 | 0.340 |
Why?
| | Muscle, Striated | 1 | 2010 | 5 | 0.340 |
Why?
| | Purkinje Cells | 3 | 1999 | 68 | 0.330 |
Why?
| | Sodium Channels | 3 | 1999 | 62 | 0.320 |
Why?
| | Protein Structure, Tertiary | 6 | 2015 | 859 | 0.310 |
Why?
| | Binding Sites | 6 | 2018 | 1310 | 0.310 |
Why?
| | Myofibrils | 1 | 2009 | 48 | 0.300 |
Why?
| | Microtubules | 4 | 1999 | 280 | 0.300 |
Why?
| | Calcium Channel Agonists | 4 | 2013 | 12 | 0.300 |
Why?
| | Synaptic Transmission | 4 | 2009 | 289 | 0.290 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2008 | 15 | 0.280 |
Why?
| | Protein Conformation | 9 | 2010 | 939 | 0.280 |
Why?
| | Transfection | 7 | 2012 | 934 | 0.280 |
Why?
| | Streptavidin | 1 | 2007 | 14 | 0.280 |
Why?
| | Spinal Cord | 3 | 1999 | 371 | 0.260 |
Why?
| | Structure-Activity Relationship | 7 | 2010 | 566 | 0.240 |
Why?
| | Green Fluorescent Proteins | 6 | 2005 | 396 | 0.240 |
Why?
| | Protein Structure, Secondary | 6 | 2012 | 372 | 0.230 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2025 | 19 | 0.230 |
Why?
| | omega-Conotoxins | 2 | 1996 | 4 | 0.230 |
Why?
| | Electric Conductivity | 11 | 2001 | 86 | 0.220 |
Why?
| | Protein Isoforms | 2 | 2021 | 392 | 0.220 |
Why?
| | Potassium | 5 | 2006 | 142 | 0.210 |
Why?
| | Models, Biological | 8 | 2010 | 1780 | 0.210 |
Why?
| | Halothane | 1 | 2023 | 6 | 0.210 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2023 | 10 | 0.210 |
Why?
| | Fluorescent Dyes | 3 | 2001 | 315 | 0.210 |
Why?
| | Protein Domains | 1 | 2025 | 289 | 0.200 |
Why?
| | Rats | 14 | 2018 | 5544 | 0.200 |
Why?
| | Recombinant Proteins | 5 | 2014 | 1343 | 0.190 |
Why?
| | Myocardial Contraction | 3 | 2012 | 302 | 0.190 |
Why?
| | Heat-Shock Response | 1 | 2023 | 76 | 0.190 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2008 | 392 | 0.190 |
Why?
| | Sinoatrial Node | 1 | 2022 | 27 | 0.190 |
Why?
| | Fluorescence Resonance Energy Transfer | 3 | 2012 | 173 | 0.190 |
Why?
| | Microscopy, Confocal | 4 | 2005 | 321 | 0.190 |
Why?
| | Signal Transduction | 9 | 2017 | 5047 | 0.180 |
Why?
| | Sodium | 5 | 2011 | 199 | 0.180 |
Why?
| | Fluoresceins | 1 | 2001 | 47 | 0.180 |
Why?
| | Cysteine | 2 | 2005 | 202 | 0.180 |
Why?
| | Cytoplasm | 3 | 2012 | 265 | 0.180 |
Why?
| | Calcium Channels, T-Type | 1 | 2003 | 96 | 0.170 |
Why?
| | Bacterial Proteins | 4 | 2012 | 895 | 0.170 |
Why?
| | Organometallic Compounds | 1 | 2001 | 110 | 0.170 |
Why?
| | Mice, Knockout | 4 | 2016 | 2999 | 0.170 |
Why?
| | Humans | 21 | 2025 | 136962 | 0.160 |
Why?
| | Cerebellum | 2 | 2018 | 214 | 0.160 |
Why?
| | Lambert-Eaton Myasthenic Syndrome | 2 | 1996 | 3 | 0.160 |
Why?
| | Caffeine | 6 | 2012 | 67 | 0.160 |
Why?
| | Receptor Cross-Talk | 1 | 1999 | 21 | 0.160 |
Why?
| | Manganese | 2 | 2009 | 56 | 0.150 |
Why?
| | Biotinylation | 2 | 2012 | 33 | 0.150 |
Why?
| | Mice, Neurologic Mutants | 1 | 1998 | 21 | 0.150 |
Why?
| | Prosencephalon | 1 | 2018 | 48 | 0.150 |
Why?
| | Electric Stimulation | 8 | 2004 | 272 | 0.150 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 505 | 0.140 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2156 | 0.140 |
Why?
| | Blood Proteins | 1 | 2000 | 245 | 0.140 |
Why?
| | Alternative Splicing | 1 | 1999 | 226 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2005 | 369 | 0.130 |
Why?
| | Ions | 2 | 2008 | 67 | 0.130 |
Why?
| | Chimera | 2 | 1996 | 60 | 0.130 |
Why?
| | Nervous System Diseases | 1 | 2000 | 270 | 0.130 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2574 | 0.130 |
Why?
| | Subcellular Fractions | 1 | 2016 | 79 | 0.130 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 66 | 0.120 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 58 | 0.120 |
Why?
| | Proteins | 1 | 2001 | 1003 | 0.120 |
Why?
| | Polymerase Chain Reaction | 3 | 2004 | 1045 | 0.120 |
Why?
| | Calmodulin | 2 | 2008 | 72 | 0.120 |
Why?
| | Oxadiazoles | 2 | 1992 | 32 | 0.110 |
Why?
| | Fluorescence | 2 | 2012 | 157 | 0.110 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 26 | 0.110 |
Why?
| | DNA | 7 | 1993 | 1441 | 0.110 |
Why?
| | Developmental Disabilities | 1 | 2017 | 266 | 0.110 |
Why?
| | Motor Endplate | 3 | 1986 | 15 | 0.110 |
Why?
| | Bone and Bones | 1 | 1996 | 318 | 0.100 |
Why?
| | Plasmids | 6 | 1994 | 358 | 0.100 |
Why?
| | Cell Fusion | 2 | 1990 | 51 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 897 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2463 | 0.100 |
Why?
| | Triclosan | 1 | 2012 | 10 | 0.100 |
Why?
| | Adenosine | 1 | 1994 | 221 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2012 | 112 | 0.100 |
Why?
| | Anti-Infective Agents, Local | 1 | 2012 | 40 | 0.090 |
Why?
| | Biotin | 1 | 2012 | 28 | 0.090 |
Why?
| | Time Factors | 6 | 2010 | 6786 | 0.090 |
Why?
| | Barium | 4 | 1998 | 26 | 0.090 |
Why?
| | Cloning, Molecular | 3 | 2001 | 534 | 0.090 |
Why?
| | Fibroblasts | 3 | 1990 | 997 | 0.080 |
Why?
| | Sarcomeres | 2 | 2009 | 93 | 0.080 |
Why?
| | Amino Acid Substitution | 2 | 2002 | 304 | 0.080 |
Why?
| | Muscle Development | 4 | 1993 | 112 | 0.080 |
Why?
| | Dantrolene | 1 | 2009 | 5 | 0.080 |
Why?
| | Oligopeptides | 2 | 2001 | 269 | 0.080 |
Why?
| | Nifedipine | 1 | 2009 | 28 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2807 | 0.070 |
Why?
| | Hindlimb | 1 | 1989 | 127 | 0.070 |
Why?
| | Point Mutation | 2 | 2001 | 237 | 0.070 |
Why?
| | Night Blindness | 1 | 2008 | 6 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 1990 | 132 | 0.070 |
Why?
| | Muscular Dystrophies | 1 | 1988 | 36 | 0.070 |
Why?
| | Ataxia | 1 | 2008 | 70 | 0.070 |
Why?
| | In Vitro Techniques | 3 | 1997 | 1085 | 0.070 |
Why?
| | Embryo, Nonmammalian | 1 | 1988 | 168 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 229 | 0.070 |
Why?
| | Embryo, Mammalian | 1 | 1988 | 234 | 0.070 |
Why?
| | Heterozygote | 1 | 2008 | 305 | 0.070 |
Why?
| | Protein Interaction Mapping | 1 | 2007 | 106 | 0.070 |
Why?
| | Mutagenesis | 2 | 2001 | 182 | 0.070 |
Why?
| | Biophysical Phenomena | 2 | 1997 | 64 | 0.060 |
Why?
| | Receptors, Cholinergic | 4 | 1990 | 38 | 0.060 |
Why?
| | Biophysics | 2 | 1997 | 71 | 0.060 |
Why?
| | Genes, Lethal | 1 | 1986 | 30 | 0.060 |
Why?
| | Chick Embryo | 3 | 1991 | 127 | 0.060 |
Why?
| | Temperature | 3 | 1985 | 669 | 0.060 |
Why?
| | Taste | 1 | 1988 | 229 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2012 | 5733 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2012 | 1301 | 0.060 |
Why?
| | Xanthenes | 2 | 1994 | 10 | 0.060 |
Why?
| | Reference Values | 2 | 1996 | 797 | 0.060 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1997 | 114 | 0.050 |
Why?
| | Ganglia, Spinal | 2 | 1996 | 77 | 0.050 |
Why?
| | Aniline Compounds | 2 | 1994 | 101 | 0.050 |
Why?
| | Age Factors | 3 | 2012 | 3258 | 0.050 |
Why?
| | Rats, Inbred Strains | 4 | 1985 | 345 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2371 | 0.050 |
Why?
| | Potassium Channels | 2 | 1997 | 147 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2007 | 734 | 0.050 |
Why?
| | Magnesium | 1 | 2003 | 155 | 0.050 |
Why?
| | Light | 1 | 2005 | 390 | 0.050 |
Why?
| | Isradipine | 2 | 1995 | 3 | 0.050 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2022 | 66 | 0.050 |
Why?
| | Models, Structural | 3 | 1997 | 40 | 0.050 |
Why?
| | RNA, Messenger | 3 | 1998 | 2788 | 0.050 |
Why?
| | Allosteric Regulation | 1 | 2001 | 94 | 0.050 |
Why?
| | Restriction Mapping | 2 | 1999 | 75 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2001 | 108 | 0.040 |
Why?
| | CHO Cells | 1 | 2001 | 165 | 0.040 |
Why?
| | Gestational Age | 2 | 2017 | 902 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2002 | 100 | 0.040 |
Why?
| | Cricetinae | 1 | 2001 | 294 | 0.040 |
Why?
| | Amiloride | 2 | 1992 | 26 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2001 | 168 | 0.040 |
Why?
| | Culture Techniques | 2 | 1991 | 73 | 0.040 |
Why?
| | Cyclic GMP | 2 | 1978 | 91 | 0.040 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 59 | 0.040 |
Why?
| | Tetrodotoxin | 3 | 1990 | 40 | 0.040 |
Why?
| | Microscopy, Electron | 3 | 2012 | 433 | 0.040 |
Why?
| | Mammals | 1 | 2002 | 287 | 0.040 |
Why?
| | NAV1.6 Voltage-Gated Sodium Channel | 1 | 1999 | 11 | 0.040 |
Why?
| | Tetraethylammonium Compounds | 2 | 1990 | 8 | 0.040 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2000 | 75 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2002 | 481 | 0.040 |
Why?
| | Protein Folding | 1 | 2001 | 276 | 0.040 |
Why?
| | Peptides | 2 | 1996 | 975 | 0.040 |
Why?
| | Conserved Sequence | 2 | 1997 | 235 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2000 | 409 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2046 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2001 | 613 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2000 | 408 | 0.040 |
Why?
| | Heart Rate | 1 | 2022 | 794 | 0.040 |
Why?
| | omega-Agatoxin IVA | 1 | 1998 | 1 | 0.040 |
Why?
| | Spider Venoms | 1 | 1998 | 11 | 0.040 |
Why?
| | Microelectrodes | 2 | 2012 | 45 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 1998 | 52 | 0.040 |
Why?
| | Mice, Inbred C3H | 1 | 1998 | 268 | 0.040 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 129 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2001 | 607 | 0.030 |
Why?
| | Gene Expression | 1 | 2003 | 1480 | 0.030 |
Why?
| | Zebrafish | 1 | 2022 | 499 | 0.030 |
Why?
| | Shaker Superfamily of Potassium Channels | 1 | 1997 | 4 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 1997 | 65 | 0.030 |
Why?
| | Electrochemistry | 1 | 1997 | 76 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2001 | 551 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1997 | 226 | 0.030 |
Why?
| | Nimodipine | 1 | 1996 | 6 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1997 | 354 | 0.030 |
Why?
| | Leucine | 1 | 1997 | 111 | 0.030 |
Why?
| | Papillary Muscles | 1 | 1996 | 12 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2017 | 193 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2000 | 690 | 0.030 |
Why?
| | Gap Junctions | 1 | 1997 | 59 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 439 | 0.030 |
Why?
| | Blood | 1 | 1996 | 108 | 0.030 |
Why?
| | Molecular Structure | 1 | 1997 | 493 | 0.030 |
Why?
| | Snakes | 2 | 1986 | 22 | 0.030 |
Why?
| | Cadmium Chloride | 1 | 1995 | 4 | 0.030 |
Why?
| | Barium Compounds | 1 | 1995 | 8 | 0.030 |
Why?
| | Models, Molecular | 1 | 2000 | 1591 | 0.030 |
Why?
| | Lanthanum | 1 | 1995 | 13 | 0.030 |
Why?
| | Cadmium | 1 | 1995 | 69 | 0.030 |
Why?
| | omega-Conotoxin GVIA | 1 | 1994 | 5 | 0.030 |
Why?
| | Adenosine-5'-(N-ethylcarboxamide) | 1 | 1994 | 10 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 1994 | 79 | 0.030 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1994 | 21 | 0.030 |
Why?
| | Reaction Time | 1 | 1996 | 416 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 1997 | 359 | 0.030 |
Why?
| | Membranes | 1 | 1994 | 17 | 0.030 |
Why?
| | Chlorides | 1 | 1995 | 135 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 40 | 0.030 |
Why?
| | Phosphorylation | 1 | 1998 | 1746 | 0.030 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 1994 | 33 | 0.030 |
Why?
| | Swine | 1 | 1996 | 778 | 0.030 |
Why?
| | 3T3 Cells | 1 | 1993 | 164 | 0.020 |
Why?
| | Nicotinic Acids | 1 | 1992 | 5 | 0.020 |
Why?
| | Mathematics | 2 | 1983 | 101 | 0.020 |
Why?
| | Water Pollutants | 1 | 2012 | 20 | 0.020 |
Why?
| | Synapses | 2 | 1996 | 415 | 0.020 |
Why?
| | Cyprinidae | 1 | 2012 | 21 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 128 | 0.020 |
Why?
| | Male | 6 | 2017 | 67385 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2012 | 97 | 0.020 |
Why?
| | Organ Specificity | 1 | 1993 | 305 | 0.020 |
Why?
| | Child Development | 1 | 2017 | 466 | 0.020 |
Why?
| | Executive Function | 1 | 2017 | 450 | 0.020 |
Why?
| | Algorithms | 1 | 1999 | 1699 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1991 | 156 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2066 | 0.020 |
Why?
| | Anesthetics | 1 | 2012 | 80 | 0.020 |
Why?
| | Body Temperature | 1 | 2012 | 220 | 0.020 |
Why?
| | Tetraethylammonium | 1 | 1990 | 16 | 0.020 |
Why?
| | Cell Death | 1 | 1992 | 370 | 0.020 |
Why?
| | 4-Aminopyridine | 1 | 1990 | 24 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1992 | 265 | 0.020 |
Why?
| | Extremities | 1 | 1990 | 130 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 1989 | 78 | 0.020 |
Why?
| | Freeze Fracturing | 2 | 2002 | 4 | 0.020 |
Why?
| | Tropomyosin | 1 | 1989 | 13 | 0.020 |
Why?
| | DNA Probes | 1 | 1989 | 58 | 0.020 |
Why?
| | Verapamil | 1 | 1989 | 37 | 0.020 |
Why?
| | Muscular Dystrophy, Animal | 1 | 1989 | 9 | 0.020 |
Why?
| | Embryonic and Fetal Development | 1 | 1989 | 95 | 0.020 |
Why?
| | Phylogeny | 1 | 1993 | 1003 | 0.020 |
Why?
| | Sarcolemma | 1 | 1989 | 42 | 0.020 |
Why?
| | Creatine Kinase | 1 | 1989 | 75 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 1989 | 188 | 0.020 |
Why?
| | Base Sequence | 1 | 1992 | 2168 | 0.020 |
Why?
| | Necturus | 1 | 1988 | 14 | 0.020 |
Why?
| | Female | 3 | 2017 | 73001 | 0.020 |
Why?
| | Myosins | 1 | 1989 | 135 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 1990 | 177 | 0.020 |
Why?
| | Genetic Markers | 1 | 1989 | 346 | 0.020 |
Why?
| | Dystrophin | 1 | 1988 | 35 | 0.020 |
Why?
| | Stereoisomerism | 1 | 1988 | 98 | 0.020 |
Why?
| | Genes | 1 | 1988 | 228 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 222 | 0.020 |
Why?
| | Motor Activity | 1 | 2012 | 714 | 0.020 |
Why?
| | Dimerization | 1 | 2008 | 195 | 0.020 |
Why?
| | Brain | 2 | 1997 | 2711 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1988 | 514 | 0.020 |
Why?
| | Actins | 1 | 1989 | 415 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1993 | 1452 | 0.020 |
Why?
| | Histological Techniques | 1 | 1986 | 40 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1986 | 318 | 0.010 |
Why?
| | Cations | 1 | 2005 | 83 | 0.010 |
Why?
| | Stem Cells | 1 | 1990 | 595 | 0.010 |
Why?
| | Tendons | 1 | 1986 | 110 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2017 | 6051 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 1985 | 69 | 0.010 |
Why?
| | Quality of Life | 1 | 2017 | 2899 | 0.010 |
Why?
| | Prospective Studies | 1 | 2017 | 7512 | 0.010 |
Why?
| | Rubidium | 1 | 1983 | 13 | 0.010 |
Why?
| | Evoked Potentials | 1 | 1983 | 124 | 0.010 |
Why?
| | Cell Differentiation | 1 | 1989 | 1985 | 0.010 |
Why?
| | Kidney | 1 | 1989 | 1466 | 0.010 |
Why?
| | Liver | 1 | 1989 | 1867 | 0.010 |
Why?
| | Rana pipiens | 2 | 1978 | 20 | 0.010 |
Why?
| | Tumor Cells, Cultured | 2 | 1993 | 942 | 0.010 |
Why?
| | Pregnancy | 1 | 1992 | 6736 | 0.010 |
Why?
| | United States | 1 | 2017 | 14945 | 0.010 |
Why?
| | Thoracica | 1 | 1977 | 2 | 0.010 |
Why?
| | Potassium Chloride | 1 | 1977 | 40 | 0.010 |
Why?
| | Glutamates | 1 | 1977 | 58 | 0.010 |
Why?
| | Child | 1 | 2017 | 21760 | 0.010 |
Why?
| | Ethylamines | 1 | 1976 | 5 | 0.010 |
Why?
| | Lidocaine | 1 | 1976 | 39 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 1996 | 154 | 0.010 |
Why?
| | Methylamines | 1 | 1976 | 34 | 0.010 |
Why?
| | Gene Targeting | 1 | 1996 | 82 | 0.010 |
Why?
| | Ca(2+) Mg(2+)-ATPase | 1 | 1989 | 2 | 0.000 |
Why?
| | Calsequestrin | 1 | 1989 | 8 | 0.000 |
Why?
| | Calcium-Transporting ATPases | 1 | 1989 | 31 | 0.000 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1988 | 66 | 0.000 |
Why?
| | Molecular Weight | 1 | 1989 | 330 | 0.000 |
Why?
| | Pheochromocytoma | 1 | 1989 | 56 | 0.000 |
Why?
| | Cell Communication | 1 | 1989 | 315 | 0.000 |
Why?
| | Anura | 1 | 1978 | 46 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1978 | 217 | 0.000 |
Why?
|
|
Beam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|